S&P 500 7,353.73 −4.36%
Nasdaq 24,315.00 −5.52%
S&P/TSX 35,605.27 −2.03%
Apple 344.17 −1.53%
Nvidia 181.60 −9.26%
Microsoft 535.93 −3.58%
Shopify 201.23 −5.40%
Royal Bank 285.86 −2.29%
CAD/USD 0.7111 −0.65%
PRE-MKT · 06:20 ET
Market ClerkRecap
Fri Nov 6 · pre-market2 signals on Nov 5249 insider buys this week · $450MCIRO short report next: Nov 15The week ahead
RC
INSIDER · 3 COMPANIES · DIRECTOR

RA CAPITAL MANAGEMENT, L.P.

Every open-market transaction filed under this name, Sep 17 to Nov 2. The same name appears at more than one issuer; filings don’t say whether it’s one person.

Filings
9
4 buys · 5 sells
Bought
$46.6M
open market, at cost
Sold
$31M
includes scheduled sales
Buys since
+5.4%
avg move from buy price, 4 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2BBTXBambusa Therapeutics, Inc.DirectorBuy164,891$16.00$2.6M+0.4%
Nov 2BBTXBambusa Therapeutics, Inc.DirectorBuy2,335,109$16.00$37.4M+0.4%
Oct 30BBTXBambusa Therapeutics, Inc.DirectorBuy263,911$14.92$3.9M+7.7%
Oct 30BBTXBambusa Therapeutics, Inc.DirectorBuy189,909$14.23$2.7M+12.9%
Oct 29LENZLENZ Therapeutics, Inc.10% ownerSell107,170$3.36$360K+4.2%
Oct 29LENZLENZ Therapeutics, Inc.10% ownerSell451,998$3.36$1.5M+4.2%
Oct 29LENZLENZ Therapeutics, Inc.10% ownerSell2,159,516$3.36$7.3M+4.2%
Sep 17SIONSionna Therapeutics, Inc.DirectorSell33,800$7.46$252K—
Sep 17SIONSionna Therapeutics, Inc.DirectorSell3,415,011$6.32$21.6M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.